Higher sexual interest with androgen receptor inhibitor monotherapy than with castration plus an androgen receptor inhibitor in prostate cancer patients treated with curative radiotherapy, but otherwise small health-related quality of life differences: A randomised prospective 18-month follow-up study-Reference-Cited by-同舟云学术

Higher sexual interest with androgen receptor inhibitor monotherapy than with castration plus an androgen receptor inhibitor in prostate cancer patients treated with curative radiotherapy, but otherwise small health-related quality of life differences: A randomised prospective 18-month follow-up study

Published:2016-09 Issue: Volume:65 Page:43-51
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Majumder Khairul,Nilsson Sten,Johansson Hemming,Ullén Anders,Lennernäs Bo,Bergenmar Mia,Brandberg Yvonne

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference19 articles.

1. Use of androgen deprivation therapy in prostate cancer: indications and prevalence;Connolly;Asian Androl,2012

2. Bicalutamide monotherapy compared with castration in patients with nonmetastatic locally advanced prostate cancer: 6.3 years of followup;Iversen;J Urol,2000

3. Quality of life following localized prostate cancer treated initially with androgen deprivation therapy or no therapy;Protosky;J Natl Cancer Inst,2002

4. Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group;Pilepich;Urolology,1995

5. Biochemical outcome following external beam radiation therapy with or without androgen suppression therapy for clinically localized prostate cancer;D'Amico;JAMA,2000

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect on prostate volume following neoadjuvant treatment with an androgen receptor inhibitor monotherapy versus castration plus an androgen receptor inhibitor in prostate cancer patients intended for curative radiation therapy: A randomised study;Molecular and Clinical Oncology;2017-11-03